Neuroglioblastoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Karyopharm Expanded Access Program for Selinexor (NCT07215832) | Karyopharm Therapeutics Inc |
Track Neuroglioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.